Chronic inflammatory demyelinating polyradiculoneuropathy and Memory loss

Summary:

Memory loss is found among people with Chronic inflammatory demyelinating polyradiculoneuropathy, especially for people who are male, 60+ old.

The study analyzes which people have Memory loss with Chronic inflammatory demyelinating polyradiculoneuropathy. It is created by eHealthMe based on reports of 34 people who have Chronic inflammatory demyelinating polyradiculoneuropathy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Chronic inflammatory demyelinating polyradiculoneuropathy?

Chronic inflammatory demyelinating polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord) is found to be associated with 118 drugs and 338 conditions by eHealthMe. Check the latest studies of Chronic inflammatory demyelinating polyradiculoneuropathy.

What is Memory loss?

Memory loss is found to be associated with 2,727 drugs and 4,376 conditions by eHealthMe. Check the latest studies of Memory loss.



On Jul, 27, 2026

34 people who have Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Memory Loss are studied.

Would you have Memory loss when you have Chronic inflammatory demyelinating polyradiculoneuropathy?

Gender of people who have Chronic Inflammatory Demyelinating Polyradiculoneuropathy and experienced Memory Loss *:

  • female: 47.06 %
  • male: 52.94 %

Age of people who have Chronic Inflammatory Demyelinating Polyradiculoneuropathy and experienced Memory Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.14 %
  • 40-49: 0.0 %
  • 50-59: 10.71 %
  • 60+: 82.14 %

Common co-existing conditions for these people *:

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 20.59%
  2. Neuropathy Peripheral (surface nerve damage): 5 people, 14.71%
  3. Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 3 people, 8.82%
  4. Pain: 2 people, 5.88%
  5. Multifocal Motor Neuropathy (a progressively worsening condition where muscles in the extremities gradually weaken): 2 people, 5.88%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.88%
  7. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.94%
  8. Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 1 person, 2.94%
  9. Muscle Spasms (muscle contraction): 1 person, 2.94%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.94%

Common drugs taken by these people *:

  1. Gabapentin: 6 people, 17.65%
  2. Vitamin D3: 4 people, 11.76%
  3. Sodium Chloride: 4 people, 11.76%
  4. Cerdelga: 4 people, 11.76%
  5. Acetaminophen: 4 people, 11.76%
  6. Vitamin B12: 4 people, 11.76%
  7. Tylenol: 4 people, 11.76%
  8. Topamax: 3 people, 8.82%
  9. Metformin: 3 people, 8.82%
  10. Aspirin: 3 people, 8.82%

Common symptoms for these people *:

  1. Fall: 9 people, 26.47%
  2. Headache (pain in head): 9 people, 26.47%
  3. Drug Ineffective: 9 people, 26.47%
  4. Pain: 8 people, 23.53%
  5. Executive Dysfunction: 7 people, 20.59%
  6. Head Injury: 7 people, 20.59%
  7. Acute Cerebellar Ataxia (disorder of the nervous system-sudden onset of a disturbance in coordination): 7 people, 20.59%
  8. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 20.59%
  9. Fatigue (feeling of tiredness): 5 people, 14.71%
  10. Drowsiness: 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Memory loss:

All the conditions that are associated with Memory loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Chronic inflammatory demyelinating polyradiculoneuropathy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: